Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals
Hand-out
Press Releases
Alpha-9 Oncology, Inc.  
October 23, 2024

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals

Series C led by Lightspeed Venture Partners and Ascenta Capital with participation from top-tier new investor syndicate and existing investorsFunding will advance distinctive pipeline of targeted radiopharmaceuticals through clinical studies

avatar profile Olean Times Herald

Olean Times Herald


Local & Social